Last reviewed · How we verify
Amoxicillin Pill
At a glance
| Generic name | Amoxicillin Pill |
|---|---|
| Sponsor | University Hospitals Cleveland Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans (PHASE3)
- Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age (PHASE4)
- Zuojin Wan Combined with Vonoprazan-Amoxicillin Dual Therapy in H.Pylori Eradication (EARLY_PHASE1)
- Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair (PHASE4)
- Dose and Duration of Metronidazole and Amoxicillin for Treatment of Chronic Periodontitis (PHASE4)
- Amoxicillin and Metronidazole in Association With Non-surgical Therapy in Aggressive Periodontitis Treatment (PHASE4)
- Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy in Acute Cholecystitis (PHASE4)
- Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Amoxicillin Pill CI brief — competitive landscape report
- Amoxicillin Pill updates RSS · CI watch RSS
- University Hospitals Cleveland Medical Center portfolio CI